4:04pm ET
Investing
Biostage, Fossil Group Tumble into Friday’s 52-Week Low Club
Biostage, Fossil Group, Galena Biopharma, and Himax posted new 52-week lows on Friday.
Companies
Galena Biopharma, Inc.
$0.26
▼ $0.01 (−5.11%) today
Markets closed · 10:45pm ET
Today · % change
GALE Coverage
4:08pm ET
Investing
Gilead Sciences, Fitbit Plunge into Wednesday’s 52-Week Low Club
Gilead Sciences, Gale Biopharma, Teva, and Fitbit post new 52-week lows Wednesday.
11:35am ET
Health and Healthcare
Wednesday’s Biggest Biopharma Movers
Not that many biotech and pharma companies were on the move Wednesday, but a few of the smaller caps made splash, while one giant company posted a massive loss.
4:04pm ET
Investing
DryShips, Stage Stores Plunge into Monday’s 52-Week Low Club
DryShips, Stage Stores, Galena Biopharma, and Diplomat Pharmacy post new 52-week lows on Monday.
Paul Ausick 3:43pm ET
Health and Healthcare
Galena Rises on FDA Approval
Galena Biopharma, Inc. (NASDAQ: GALE) saw its shares jump on Wednesday after a key U.S. Food and Drug Administration (FDA) approval. The company announced that it has confirmed the regulatory pathway to…
Chris Lange 8:35am ET
Health and Healthcare
7 Key FDA Decisions and Clinical Trial Results Coming in Q4
24/7 Wall St. has collected several big FDA decisions and mid- to late-stage trials that should be coming up in November and December.
Chris Lange 9:35am ET
Health and Healthcare
4 Companies That Destroyed Shareholders Despite a Brexit Recovery
Despite Brexit absolutely rocking the market over a week ago, the broad markets made a solid comeback leading most people to believe that this was just one big head fake. Some companies made…
Chris Lange 1:21pm ET
Health and Healthcare
Is Galena Dead in the Water After This Failed Trial?
Galena Biopharma, Inc. (NASDAQ: GALE) is absolutely crashing on Wednesday after the company released further information regarding its Breast Cancer clinical trial. The company announced the recommendation from the Independent Data Monitoring…
Chris Lange 9:35am ET
Health and Healthcare
8 Major Biopharma Events Coming Later in 2016 and in 2017
FDA rulings can make or break some companies. 24/7 Wall St. has collected eight key FDA decisions coming up in 2016 or 2017.
8:05am ET
Investing
Top Wall Street Analyst Sell Ratings on High Profile Stocks This Week
ThinkstockAt 24/7 Wall Street we have been running weekly research screens to scan the brokerage firms we cover for the stocks that are cut to Underperform or Sell ratings. The higher the…
8:30am ET
Investing
Top Analyst Upgrades and Downgrades: BlackBerry, Care.com, Lululemon, Tesla, Veeco and More
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Tuesday February 18, 2014. They include BlackBerry, Care.com, Lululemon Athletica, Tesla Motors and Veeco Instruments.
8:15am ET
Health and Healthcare
Eight Biotech Stocks Trading Near $5 With Huge Upside Potential
Here are the top biotech stocks to buy that are trading near the $5 dollar level. We have updated coverage on stocks we have reported on before, and added some top new…
8:10am ET
Investing
Ten Top Wall Street Analyst Stocks to Buy Trading Just Above or Below $5
ThinkstockEvery quarter we like to review the research at the top firms we cover and look for any new stocks to buy that are priced either slightly above or under $5 per…
8:30am ET
Health and Healthcare
Biotech Stocks Under $10 With Huge Upside Potential for 2014
24/7 Wall St. ran a screen of the Wall Street firms we cover looking for biotech stocks trading under $10 that had big upside potential for 2014. These are potentially the next…
7:01am ET
Investing
Ten Top Stocks Trading Under $10 to Buy for Big 2014 Gains
ThinkstockWith less than a week left in what has been the best year for the S&P 500 since 1997, we have reviewed our top Wall Street firms for their stocks priced under…
